Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2019-12-16
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well temsirolimus works in treating patients with breast
cancer that has spread to other places in the body. Temsirolimus may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth.